More about
High-Burden Follicular Lymphoma
News
December 11, 2023
3 min read
Save
'Remarkable' study shows potential of chemotherapy-free regimen for follicular lymphoma
SAN DIEGO — Subcutaneous time-limited mosunetuzumab exhibited “highly encouraging efficacy” among patients with newly diagnosed high-burden follicular lymphoma, according to researchers.